ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
-14.52%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
–
AUM
$230M
AUM Growth
+$230M
Cap. Flow
+$15.9M
Cap. Flow %
6.91%
Top 10 Hldgs %
97.77%
Holding
14
New
1
Increased
2
Reduced
–
Closed
–

Top Buys

1
SNDX icon
Syndax Pharmaceuticals
SNDX
$9.6M
2
BBIO icon
BridgeBio Pharma
BBIO
$4.46M
3
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
$1.82M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$116M 50.4% 3,989,412 +153,690 +4% +$4.46M
EIDX
2
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$55M 23.98% 1,123,630 – –
TECX
3
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$15.7M 6.84% 1,009,779 +116,700 +13% +$1.82M
SNDX icon
4
Syndax Pharmaceuticals
SNDX
$1.41B
$9.6M 4.18% +875,000 New +$9.6M
BCEL
5
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$6.42M 2.8% 387,653 – –
SYRE icon
6
Spyre Therapeutics
SYRE
$996M
$6.02M 2.62% 1,291,151 – –
RCUS icon
7
Arcus Biosciences
RCUS
$1.13B
$4.63M 2.02% 333,333 – –
VIRX
8
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4.19M 1.83% 10,100,000 – –
MRKR icon
9
Marker Therapeutics
MRKR
$12M
$3.8M 1.66% 2,000,000 – –
OBSV
10
DELISTED
ObsEva SA Ordinary Shares
OBSV
$3.34M 1.46% 1,386,338 – –
VRNA
11
Verona Pharma
VRNA
$9.16B
$1.83M 0.8% 443,596 – –
ZSAN
12
DELISTED
Zosano Pharma Corporation
ZSAN
$1.53M 0.67% 2,718,226 – –
NBRV
13
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$1.1M 0.48% 1,910,287 – –
ACRS icon
14
Aclaris Therapeutics
ACRS
$209M
$660K 0.29% 634,455 – –